Nanobiotix SA
F:5NR
Nanobiotix SA
F:5NR
Price:
26.5
EUR
-5.42%
Market Cap:
€1.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Nanobiotix SA
F:5NR
|
FR |
|
NatWest Group PLC
F:RYS
|
UK |
|
Siemens AG
MIL:1SIE
|
DE |
|
F
|
F5 Inc
XMUN:FFV
|
US |
|
G
|
Gen Digital Inc
F:SYM
|
US |
|
Old Dominion Freight Line Inc
NASDAQ:ODFL
|
US |
|
Kaiser Reef Ltd
F:7YR
|
AU |
|
M
|
Microstrategy Inc
F:MIGA
|
US |
|
F
|
Frey SA
F:943
|
FR |
|
F
|
Frey SA
PAR:FREY
|
FR |
|
I
|
Insulet Corp
XMUN:GOV
|
US |
|
Aurora Cannabis Inc
F:21P
|
CA |
|
Pernod Ricard SA
PAR:RI
|
FR |
|
A
|
Abbott Laboratories
F:ABL
|
US |
|
P
|
PICC Property and Casualty Co Ltd
OTC:PPCCF
|
CN |
|
P
|
Public Storage
F:PUP
|
US |
|
Microstrategy Inc
NASDAQ:MSTR
|
US |
|
P
|
PICC Property and Casualty Co Ltd
XMUN:PJC
|
CN |
Intrinsic Value
Not Available for 5NR
There is not enough data to reliably calculate the intrinsic value for Nanobiotix SA.
Do our valuations actually work? See backtest results .
Alternatives to 5NR
Fundamental Analysis
What Nanobiotix Does
Nanobiotix is a French biotechnology company focused on cancer treatment. Its main product is a nanoparticle-based therapy that is designed to be injected into a tumor and activated by radiotherapy, with the goal of making radiation kill more cancer cells while limiting damage to healthy tissue. The company is still building this into an approved medical business rather than selling a broad range of medicines.
- Headquarters
- France FR
- Employees
- 100
- IPO date
- Oct 29, 2012
Financials
Efficiency
Earnings Waterfall
Nanobiotix SA
Nanobiotix SA
